Delivery Order SPE2DB20D3103-SPE2DB24FP3P5

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of Fosamax 70 mg tablets to the Defense Logistics Agency (DLA). The $3,092.93 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $7,508.24, is for the delivery of Fosamax 70 mg tablets and has a completion date of January 13, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The award, valued at $4,008.21, is for the delivery of Fosamax 70 MG Tablet pharmaceutical products to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order that runs through January 14, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $6,124.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract covers the delivery of FOSAMAX 70 MG TABLET UU 4S, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,002.10 firm fixed-price delivery order is for the supply of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
The federal contract award, valued at $11,310.89, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which has no set-aside designation, is a Delivery Order under an Indefinite Delivery Contract (IDC) for the provision of medical supplies, including the pharmaceutical product Fosamax 70 mg tablets. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is a key vendor for federal healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $15,113.42 and is a firm fixed-price delivery order contract that runs through December 19, 2024. The award is for the provision of FOSAMAX 70 MG TABLET medication. No set-aside designation was used for this contract. AmerisourceBergen is a critical vendor for federal healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,509.35 delivery order contract is for the provision of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product. The contract has a period of performance through April 28, 2023 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,671.60 firm fixed-price delivery order is for the supply of alendronate sodium 70 mg tablets. The contract has a period of performance through May 22, 2023 and is not associated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP3P5
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order under a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,664.75, is for the supply of Fosamax 70 mg tablets to support federal healthcare programs.

The IDC held by AmerisourceBergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through November 2026. This contract vehicle enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:43 AM